AAIC 2025 Abstract
Neuron‐Derived Extracellular Vesicles as a Blood‐Based Biomarker for Alpha‐Synuclein Across Synucleinopathies
Study in peopleBiomarkers
Abstract
Background: Lewy body pathology, a hallmark of synucleinopathies, is present in most Parkinson’s disease patients and approximately 30% of dementia cases, affecting over 24 million people worldwide.
